KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cintas (CTAS) Cash & Equivalents (2016 - 2025)

Cintas' Cash & Equivalents history spans 17 years, with the latest figure at $200.8 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 64.09% year-over-year to $200.8 million; the TTM value through Nov 2025 reached $200.8 million, up 64.09%, while the annual FY2025 figure was $264.0 million, 22.82% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $200.8 million at Cintas, up from $138.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $553.6 million in Q1 2021 and bottomed at $74.6 million in Q3 2022.
  • The 5-year median for Cash & Equivalents is $117.8 million (2021), against an average of $175.3 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 239.5% in 2021 before it plummeted 84.8% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $113.2 million in 2021, then dropped by 20.65% to $89.8 million in 2022, then decreased by 4.72% to $85.6 million in 2023, then soared by 43.06% to $122.4 million in 2024, then soared by 64.09% to $200.8 million in 2025.
  • Per Business Quant, the three most recent readings for CTAS's Cash & Equivalents are $200.8 million (Q4 2025), $138.1 million (Q3 2025), and $264.0 million (Q2 2025).